Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.22 is 89% above its 5-year average of -11.33, near the high end of its 5-year range (-23.65–-1.22).
47.86% above its 12-month average of -2.34.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -0.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:22:57.015Z. Historical observations retain their original dates. Historical series through 2018-02-14.
EARNINGS PER SHARE (EPS)
-1.22
EARNINGS PER SHARE (EPS) AVG TTM
-2.34
EARNINGS PER SHARE (EPS) AVG 3Y
-6.29
EARNINGS PER SHARE (EPS) AVG 5Y
-11.33
EARNINGS PER SHARE (EPS) AVG 10Y
-38.45
EARNINGS PER SHARE (EPS) AVG 15Y
-59.25
EARNINGS PER SHARE (EPS) AVG 20Y
-141.50
CURRENT VS TTM AVG
+47.86%
CURRENT VS 3Y AVG
+80.62%
CURRENT VS 5Y AVG
+89.24%
CURRENT VS 10Y AVG
+96.83%
CURRENT VS 15Y AVG
+97.94%
CURRENT VS 20Y AVG
+99.14%
Sonoma Pharmaceuticals, Inc.
Market Cap
$5.79M
Earnings Per Share (EPS)
-1.22
TTM Avg
-2.34
3Y Avg
-6.29
5Y Avg
-11.33
Market Cap
$5.86M
Earnings Per Share (EPS)
-1.35
TTM Avg
-3.54
3Y Avg
-9.29
5Y Avg
-9.12
Market Cap
$5.70M
Earnings Per Share (EPS)
-520.08
TTM Avg
-794.41
3Y Avg
-1655.89
5Y Avg
-3031.26
Market Cap
$5.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-258.25
3Y Avg
-228.81
5Y Avg
-176.13
Market Cap
$5.89M
Earnings Per Share (EPS)
-2.92
TTM Avg
-6.51
3Y Avg
-19.53
5Y Avg
-13.36
Market Cap
$5.89M
Earnings Per Share (EPS)
537.52
TTM Avg
197.33
3Y Avg
123.75
5Y Avg
69.48
Market Cap
$5.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.92
3Y Avg
-0.62
5Y Avg
-0.53
Market Cap
$5.59M
Earnings Per Share (EPS)
-3.55
TTM Avg
-11.46
3Y Avg
-17.07
5Y Avg
-17.09
Market Cap
$5.34M
Earnings Per Share (EPS)
-1.27
TTM Avg
-3.56
3Y Avg
-24.18
5Y Avg
-53.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | $5.79M | -1.22 | -2.34 | -6.29 | -11.33 |
| Lucyd, Inc (LUCY)vs › | $5.86M | -1.35 | -3.54 | -9.29 | -9.12 |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | -520.08 | -794.41 | -1655.89 | -3031.26 |
| Scienture Holdings, Inc. (SCNX)vs › | $5.94M | N/A | -258.25 | -228.81 | -176.13 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.89M | -2.92 | -6.51 | -19.53 | -13.36 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.89M | 537.52 | 197.33 | 123.75 | 69.48 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.58M | N/A | -0.92 | -0.62 | -0.53 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | -3.55 | -11.46 | -17.07 | -17.09 |
| Soligenix, Inc. (SNGX)vs › | $5.34M | -1.27 | -3.56 | -24.18 | -53.12 |
| Femasys Inc. (FEMY)vs › | $6.28M | -4.57 | -13.10 | -16.05 | -14.80 |
Trailing EPS (TTM)
$-1.22
Forward EPS (Est.)
$-0.56
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -1.89 |
| 2025-03-31 | -2.79 |
| 2024-03-31 | -5.32 |
| 2023-03-31 | -15.18 |
| 2022-03-31 | -19.17 |
| 2021-03-31 | -23.65 |
| 2020-03-31 | -22.40 |
| 2019-03-31 | -127.68 |
| 2018-03-31 | -284.66 |
| 2017-03-31 | 197.61 |
| 2016-03-31 | -117.86 |
| 2015-03-31 | -130.37 |
| 2014-03-31 | 117.71 |
| 2013-03-31 | -585.02 |
| 2012-03-31 | -393.82 |
| 2011-03-31 | -470.27 |
| 2010-03-31 | -520.68 |
| 2009-03-31 | -1434.28 |
| 2008-03-31 | -5040.00 |
| 2007-03-31 | -11686.50 |
| 2006-03-31 | -5827.50 |
| 2005-03-31 | -4567.50 |
| 2004-03-31 | -2939.20 |
| 2003-03-31 | -656.45 |
| 2002-03-31 | -69.30 |
